Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress

Blood Cells, Molecules, and Diseases

Volumn 43, Issue 1, 2009, Pages 68-73

  Rocha, Susana ^a,b   Costa, Elísio ^a,b,c   Coimbra, Susana ^a,b,d   Nascimento, Henrique ^a,b   Catarino, Cristina ^a,b   Rocha Pereira, Petronila ^b,e   Quintanilha, Alexandre ^a,b   Belo, Luís ^a,b   Santos Silva, Alice ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

^d CESPU   (Portugal)

^e UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Erythrocyte membrane; Hemoglobin autoxidation; Oxidative stress; Peroxiredoxin 2

Indexed keywords

CATALASE; HEMOGLOBIN; HYDROGEN PEROXIDE; PEROXIREDOXIN 2;

ARTICLE; AUTOOXIDATION; CONTROLLED STUDY; CYTOSOL; ERYTHROCYTE AGGREGATION; ERYTHROCYTE MEMBRANE; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SENESCENCE;

EID: 68649102973     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2009.03.002     Document Type: Article

References (48)

1. + transport in erythrocyte membrane vesicles requires a cytoplasmic protein. J. Biol. Chem. 266 (1991) 18964-18968
2. Rabilloud T., Berthier R., Vinçon M., et al. Early events in erythroid differentiation: accumulation of the acidic peroxidoxin (PRP/TSA/NKEF-B). Biochem. J. 312 (1995) 699-705
3. Schröder E., Littlechild J.A., Lebedev A.A., et al. Crystal structure of decameric 2-cys peroxiredoxinfrom human erythrocytes at 1.7 A° resolution. Structure 8 (2000) 605-615
4. 2 levels in erythrocytes. Free Radic. Biol. Med. 39 (2005) 1407-1417
5. Low F.M., Hampton M.B., Peskin A.V., and Winterbourn C.C. Peroxiredoxin 2 function as a non-catalytic scavenger of low level hydrogen peroxide in the erythrocyte. Blood 109 6 (2007) 2611-2617
6. Harris J.R., Schröder E., Isupov M.N., et al. Comparison of the decameric structure of peroxiredoxin-II by transmission electron microscopy and X-ray crystallography. Biochim. Biophys. Acta 1547 (2001) 221-234
7. Wood Z.A., Schröder E., Harris J.R., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28 (2003) 32-40
8. Cha M.K., and Kim I.H. Thioredoxin-linked peroxidade from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell. Biochem. Biophys. Res. Commun. 217 3 (1995) 900-907
9. Kristensen P., Rasmussen D.E., and Kristensen B.I. Properties of thiol-specific anti-oxidant protein or calpromotin in solution. Biochem. Biophys. Res. Commun. 262 (1999) 127-131
10. Schröder E., Willis A.C., and Ponting C.P. Porcine natural-killer enhancing factor-B: oligomerization and identification as a calpain substrate in vitro. Biochim. Biophys. Acta 1384 (1998) 279-291
11. Cha M.K., Yun C.H., and Kim I.H. Interaction of human thiol-specific antioxidant protein 1 with erythrocyte plasma membrane. Biochemistry, 39 (2000) 6944-6950
12. Moore R.B., Shriver S.K., Jenkins L.D., et al. Calpromotin, a cytoplasmic protein, is associated with the formation of dense cells in sickle cell anemia. Am. J. Hematol. 56 (1997) 100-106
13. Murphy S.C., Samuel B.U., Harrison T., et al. Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection. Blood 103 5 (2004) 1920-1928
14. Plishker G.A., Chevalier D., Seinsoth L., and Moore R.B. Calcium activated potassium transport and high molecular weight forms of calpromotin. J. Biol. Chem. 267 (1992) 21839-21843
15. Rocha S., Vitorino R.M.P., Lemos-Amado F.M., et al. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of Hereditary Spherocytosis patients. Blood Cells Mol. Diseases 41 (2008) 5-9
16. Low T.Y., Seow T.K., and Chung M.C. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2 (2002) 1229-1239
17. Lim Y.S., Cha M.K., Yun C.H., et al. Purification and characterization of thiol-specific antioxidant protein from human red blood cell: a new type of antioxidant protein,. Biochem. Biophys. Res. Commun. 199 (1994) 199-206
18. Santos-Silva A., Rebelo I., Castro E.M.B., et al. Leukocyte activation, erythrocyte damage, lipid profile and oxidative stress imposed by high competition physical exercise in adolescents. Clin. Chim. Acta 306 1-2 (2001) 119-126
19. Belo L., Rebelo I., Castro E.M.B., et al. Band 3 as a marker of erythrocyte changes in pregnancy. Eur. J. Haematol. 69 3 (2002) 145-151
20. C.Catarino, I. Rebelo, L. Belo, et al., Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage, J. Perinat. Med. 37 (1) (2009) 19-27.
21. Santos-Silva A., Castro E.M.B., Teixeira N.A., et al. Altered erythrocyte membrane band 3 profile as a marker in patients at risk for cardiovascular disease. Atherosclerosis 116 2 (1995) 199-209
22. Santos-Silva A., Rebelo I., Castro E., et al. Erythrocyte damage and leukocyte activation in ischemic stroke. Clin. Chim. Acta 320 (2002) 29-35
23. Rocha-Pereira P., Santos-Silva A., Rebelo I., et al. Erythrocyte damage in mild and severe psoriasis. Br. J. Dermatol. 150 2 (2004) 232-244
24. Santos-Silva A., Castro E.M.B., Teixeira N.A., et al. Erythrocyte membrane band 3 profile imposed by cellular aging, by activated neutrophils and by neutrophilic elastase. Clin. Chim. Acta 275 (1998) 185-196
25. Zijlstra W.G., Buursma A., and Meeuwsen-van der Roest W.P. Absorption spectra of human fetal and adult oxyhemoglobin, de-oxyhemoglobin, carboxyhemoglobin, and methemoglobin. Clin. Chem. 37 (1991) 1633-1638
26. Dodge J.T., Mitchell C., and Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100 (1963) 119-130
27. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of the protein-dye binding. Anal. Biochem. 72 (1976) 248-254
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T. Nature 227 (1970) 680-685
29. Towbin H., Stahelin T., and Gordon J. Electrophoretic transfer of proteins from polycrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 9 (1979) 4350-4354
30. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86 (1978) 271-278
31. Katsube T., Sakamoto N., Kobayashi Y., et al. Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency. Am. J. Hum. Genet. 48 (1991) 799-808
32. Xu F., Quandt K.S., and Hultquist D.E. Characterization of NADPH-dependent methemoglobin reductase as a heme-binding protein present in erythrocytes and liver. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2130-2134
33. Demehin A.A., Abugo O.O., Jayakumar R., et al. Binding of hemoglobin to red cell membranes with eosin-5-maleimide-labeled band 3: analysis of centrifugation and fluorescence data. Biochemistry 41 (2002) 8630-8637
34. Salhany J.M., Cordes K.A., and Sloan R.L. Characterization of the pH dependence of hemoglobin binding to band 3. Evidence for a pH-dependent conformational change within the hemoglobin-band 3 complex. Biochim. Biophys. Acta 1371 (1998) 107-113
35. Shaklai N., Yguerabide J., and Ranney H.M. Classification and localization of hemoglobin binding sites on the red blood cell membrane. Biochemistry 16 (1977) 5593-5597
36. Walder J.A., Chatterjee R., Steck T.L., et al. The interaction of hemoglobin with the cytoplasmic domain of band 3 of the human erythrocyte membrane. J. Biol. Chem. 259 (1984) 10238-10246
37. Rice-Evans C., and Baysal E. Iron-mediated oxidative stress in erythrocytes. Biochem. J. 244 (1987) 191-196
38. Rifkind J.M., Abugo O.O., Levy A., et al. Formation of free radicals under hypoxia. In: Hochachka P.W., Lutz P.L., Sick T., Rosenthal M., and van den Thillart G. (Eds). Surviving Hypoxia: Mechanism of Control and Adaptation (1993), CRC Press, Boca Raton FL 509-525
39. Rifkind J.M., Zhang L., Levy A., and Manoharan P.T. The hypoxic stress on erythrocytes associated with superoxide formation. Free Radic. Res. Commun. 12-13 Pt. 2 (1991) 645-652
40. Nagababu E., Chrest F.J., and Rifkind J.M. Hydrogen-peroxide-induced heme degradation in red blood cells: the protective roles of catalase and glutathione peroxidase. Biochim. Biophys. Acta 1620 (2003) 211-217
41. Jacob H.S., Ingbar S.H., and Jandl J.H. Oxidative hemolysis and erythrocyte metabolism in hereditary acatalasia. J. Clin. Invest. 44 (1965) 1187-1199
42. Stuhlmeier K.M., Kao J.J., Wallbrant P., et al. Antioxidant protein 2 prevents methemoglobin formation in erythrocyte hemolysates. Eur. J. Biochemistry 270 (2003) 334-341
43. Costa E., Rocha S., Rocha-Pereira P., et al. Band 3 profile as a marker of erythrocyte changes in chronic kidney disease patients. Open Clin. Chem. J. 1 (2008) 57-63
44. Coimbra S., Castro E., Rocha-Pereira P., et al. The effect of green tea in oxidative stress. Clin. Nutr. 25 (2006) 790-796
45. Bryk R., Griffin P., and Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407 (2000) 211-215
46. Cordray P., Doyle K., Edes K., et al. Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2. J. Biol. Chem. 282 (2007) 32623-32629
47. Peskin A.V., Low F.M., Paton L.N., et al. The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents. J. Biol. Chem. 282 (2007) 11885-11892
48. Rifkind J.M., Ajmani R.S., and Heim J. Impaired hemorheology in the aged associated with oxidative stress. Adv. Exp. Med. Biol. 428 (1997) 7-13